Showing results (1481-1490 of 1,803) with videos related to
Sort By:
Pageof 181
Health Promotion Practice|August 11, 2022
Anticipated and Experienced Stigma After Testing Positive for SARS-CoV-2: A Qualitative StudyShelley N Facente, Mariah De Zuzuarregui, Darren Frank, et al.Reproductive Health|February 6, 2024
"They call me the 'Great Queen'": implementing the Malkia Klabu program to improve access to HIV self-testing and contraception for adolescent girls and young women in TanzaniaRachel Willard-Grace, F Abigail Cabrera, Camilla Bykhovsky, et al.Plos Biology|July 22, 2015
The Orphan Nuclear Receptor TLX Is an Enhancer of STAT1-Mediated Transcription and Immunity to Toxoplasma gondiiDaniel P Beiting, Shinya Hidano, Julie E Baggs, et al.Plant Physiology and Biochemistry : PPB|March 4, 2017
Simultaneous knock-down of six β-galactosidase genes in petunia petals prevents loss of pectic galactan but decreases petal strengthErin M O'Donoghue, Sheryl D Somerfield, Simon C Deroles, et al.Mbio|November 29, 2022
Toxoplasma gondii Dissemination in the Brain Is Facilitated by Infiltrating Peripheral Immune CellsChristine A Schneider, Dario X Figueroa Velez, Stephanie B Orchanian, et al.Scientific Reports|August 31, 2018
Nanospectroscopy Captures Nanoscale Compositional Zonation in Barite Solid SolutionsFlorence T Ling, Heather A Hunter, Jeffrey P Fitts, et al.Clinical Therapeutics|April 28, 2009
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety studyPaul Karpecki, Michael Depaolis, Judy A Hunter, et al.Neural Regeneration Research|March 4, 2026
Modulation of the regenerative microenvironment within acellular nerve allografts using tacrolimus improves nerve regenerationJesús A Acevedo Cintrón, Jonathon Blake Schofield, Daniel A Hunter, et al.The Journal of Dermatological Treatment|March 13, 2023
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trialJacob P Thyssen, Thomas Werfel, Sebastien Barbarot, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2012
Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27Andrew Young, Eimear Linehan, Emily Hams, et al.Pageof 181